The global cardiac mapping systems market was estimated to be worth USD 1.70 billion in 2023. By 2030, the market value is anticipated to be worth USD 3.60 billion, rising at a CAGR of 8.50% in the forecast period of 2024-2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Cardiac mapping systems are the mapping devices used to measure the heart’s electrical impulses and create an extensive three-dimensional image of the heart’s anatomy. These systems map the different cardiac arrhythmias, including tachycardia, bradycardia, and premature ventricular contractions.
Cardiac mapping systems are non-invasive and need to be placed on the chest. Cardiac mapping helps detect the spatial and temporal areas during a specific heart rhythm. The healthcare technician can perform cardiac mapping on the required area of interest for a particular heart rhythm.
A cardiac mapping system generally consists of several equipments like amplifiers, recorders, and analysing systems or analysers. Cardiac mapping is performed with the help of catheters. These catheters are inserted into the heart chambers to record the electrocardiograms, which can be visualised on screen.
The cardiac data analysis on the screen is being done to study the heart's anatomy. These catheters can be localised or positioned using the fluoroscopy technique.
According to the cardiac mapping systems market research report, the market can be categorised into the following segments:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Type
Market Breakup by Indication Type
Market Breakup by End-User
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increasing prevalence of cardiovascular disorders drives the cardiac mapping systems market growth. According to the European Health Network, around 19 million people suffer from cardiovascular diseases every year. With the growing population, there is an increase in the incidence of cardiac disorders. This is further propelling the market growth.
Due to the extensive research by clinical scientists, novel products are being discovered. The launch of these products will help in the expansion of the cardiac mapping systems market. For example, in 2020, a leading company, BioSense Webster, launched a new cardiac mapping system that is more efficient than conventional cardiac mapping systems.
Another key factor boosting the growth of this market is product approvals. The regulatory bodies of different countries have become more cooperative and approved more products, thus increasing the cardiac mapping systems market size.
For example, Abbott got approval for its cardiac mapping system, Ensite X, in Australia and Europe, providing significant impetus to the market growth.
Cardiac mapping is a broad term covering several types of mapping. The different modes of cardiac mapping are epicardial, endocardial, and body surface mapping.
There are different modes in cardiac mapping systems. Some of the major modes in cardiac mapping systems include activation mapping, entrainment mapping, and pace mapping.
Activation mapping works on the principle of electrocardiogram tracings to detect the direction and type of impulse propagation. Entrainment mapping is used to visualise the location of the circuit, which can be helpful while performing ablation. Pace mapping is another mode in which the tachycardia sources are plotted by pacing at several endocardial sites.
The cardiac mapping systems help visualise and analyse the heart’s electrical activity. This data is used to diagnose and manage cardiovascular disorders at the early stages or at the onset of that disease.
These devices also help map the heart’s anatomy before and after the ablation process. This mapping is done to ensure whether the surgery is effective or not.
The cardiac mapping systems market is majorly driven by its use in treating cardiac arrhythmias. The different arrhythmias managed by these systems include ventricular tachycardia, atrial fibrillation, ventricular bradycardia, and untimely ventricular contractions.
With the high treatment potential, the cardiac mapping systems market possesses an excellent opportunity for healthcare industries and pharmaceutical companies in extensive therapeutic and diagnostic methods.
Increasing technological advancements have paved the way for multiple approaches to cardiac mapping systems. These novel technologies provide more specific and sensitive data. The technological advancements have resulted in the production of magnetic-based mapping systems and impedance-based mapping systems., which have further aided the market growth.
The 3-D technology is used to create highly detailed images of the heart’s anatomy, which helps cardiologists detect abnormal heart rhythm regions. Such technology is likely to provide an impetus to the market growth in the coming years as well.
The emergence of hybrid magnetic and impedance-based systems has provided novel prospects in the cardiac mapping systems market. This incorporated system is being used to create the heart’s anatomical map. In this system, a magnetic system is used to get the accurate image, while impedance systems help provide users with flexibility for using any catheter.
With the advancements in electrophysiology, novel and more effective technologies have been invented. These technologies are under clinical trials and, once approved, are anticipated to drive the growth of the market during the forecast period.
The report gives an in-depth analysis of the key players involved in the cardiac mapping systems market, sponsors manufacturing the therapies, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Type||
|Breakup Demand by Indication||
|Breakup by End-User||
|Breakup by Region||
|Trade Data Analysis||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.1.1 Research Objectives
1.1.2 Key Findings of the Report
1.2 Limitations of the Study and Scope for Future Research
2 Research Methodology
3 Executive Summary
4 Global Cardiac Mapping System Market
4.1 Global Cardiac Mapping System Market Overview
4.1.1 Global Cardiac Mapping System Market Analysis
188.8.131.52 Market Overview
184.108.40.206.1 Global Cardiac Mapping System Historical Market Value (2017-2023)
220.127.116.11.2 Global Cardiac Mapping System Forecast Market Value (2024-2032)
4.1.2 Global Cardiac Mapping System Market by Type
18.104.22.168 Market Overview
22.214.171.124.1 Contact Cardiac Mapping Systems
126.96.36.199.2 Electroanatomical Mapping Systems
188.8.131.52.3 Basket Catheter Mapping Systems
184.108.40.206.4 Traditional Endocardial Catheter Mapping Systems
220.127.116.11.5 Non-Contact Cardiac Mapping Systems
4.1.3 Global Cardiac Mapping System Market demand by Indication
18.104.22.168 Market Overview
22.214.171.124.1 Atrial Fibrillation
126.96.36.199.2 Atrial Flutter
188.8.131.52.3 Atrioventricular Nodal Reentry Tachycardia (Avnrt)
184.108.40.206.4 Other Arrhythmias
4.1.4 Global Cardiac Mapping System Market by End-User
220.127.116.11 Market Overview
18.104.22.168.2 Testing Laboratories
22.214.171.124.3 Research Laboratories
4.1.5 Global Cardiac Mapping System by Region
126.96.36.199 Market Overview
188.8.131.52.1 North America
184.108.40.206.3 Asia Pacific
220.127.116.11.4 Latin America
18.104.22.168.5 Middle East & Africa
4.1.6 North America
22.214.171.124 Historical Trend (2017-2023)
126.96.36.199 Forecast Trend (2024-2032)
188.8.131.52 Break Up by Country
184.108.40.206.1 United States of America
220.127.116.11 Historical Trend (2017-2023)
18.104.22.168 Forecast Trend (2024-2032)
22.214.171.124 Break Up by Country
126.96.36.199.1 United Kingdom
4.1.8 Asia Pacific
188.8.131.52 Historical Trend (2017-2023)
184.108.40.206 Forecast Trend (2024-2032)
220.127.116.11 Break Up by Country
4.1.9 Latin America
18.104.22.168 Historical Trend (2017-2023)
22.214.171.124 Forecast Trend (2024-2032)
126.96.36.199 Break Up by Country
4.1.10 Middle East and Africa
188.8.131.52 Historical Trend (2017-2023)
184.108.40.206 Forecast Trend (2024-2032)
220.127.116.11 Break Up by Country
18.104.22.168.1 Saudi Arabia
22.214.171.124.2 United Arab Emirates
126.96.36.199.4 South Africa
5 Trade Data Analysis by HS Code
6 Regulations and Current Scenario Evaluation
6.1 Regulatory Framework
6.2 Patent Landscape
6.3 Clinical Trials Synopsis (Additional Insight)
7 Industry Dynamics
7.1 Industry Drivers and Constraints
7.2 Porter Five Forces
7.3 SWOT Analysis
7.4 Key Demand Indicators
7.5 Key Price Indicators
7.6 Industry Events, Initiatives, and Trends
7.7 Value Chain Analysis
8 Supplier Landscape
8.1 Company Profiles
8.1.1 Biosense Webster
188.8.131.52 Company Overview
184.108.40.206 Product Portfolio
220.127.116.11 Demographic Reach and Achievements
18.104.22.168 Mergers and Acquisitions
8.1.2 Abbott Laboratories
22.214.171.124 Company Overview
126.96.36.199 Product Portfolio
188.8.131.52 Demographic Reach and Achievements
184.108.40.206 Mergers and Acquisitions
8.1.3 Medtronics PLC
220.127.116.11 Company Overview
18.104.22.168 Product Portfolio
22.214.171.124 Demographic Reach and Achievements
126.96.36.199 Mergers and Acquisitions
8.1.4 Boston Scientific Corporation
188.8.131.52 Company Overview
184.108.40.206 Product Portfolio
220.127.116.11 Demographic Reach and Achievements
18.104.22.168 Mergers and Acquisitions
8.1.5 Acutus Medical
22.214.171.124 Company Overview
126.96.36.199 Product Portfolio
188.8.131.52 Demographic Reach and Achievements
184.108.40.206 Mergers and Acquisitions
8.1.6 Microport Scientific Corporation
220.127.116.11 Company Overview
18.104.22.168 Product Portfolio
22.214.171.124 Demographic Reach and Achievements
126.96.36.199 Mergers and Acquisitions
8.1.7 CoreMap Inc.
188.8.131.52 Company Overview
184.108.40.206 Product Portfolio
220.127.116.11 Demographic Reach and Achievements
18.104.22.168 Mergers and Acquisitions
8.1.8 APN Health LLC
22.214.171.124 Company Overview
126.96.36.199 Product Portfolio
188.8.131.52 Demographic Reach and Achievements
184.108.40.206 Mergers and Acquisitions
8.1.9 BioSig Technologies Inc.
220.127.116.11 Company Overview
18.104.22.168 Product Portfolio
22.214.171.124 Demographic Reach and Achievements
126.96.36.199 Mergers and Acquisitions
8.1.10 Biotronik SE and Co KG
188.8.131.52 Company Overview
184.108.40.206 Product Portfolio
220.127.116.11 Demographic Reach and Achievements
18.104.22.168 Mergers and Acquisitions
8.1.11 Koninklijke Philips NV
22.214.171.124 Company Overview
126.96.36.199 Product Portfolio
188.8.131.52 Demographic Reach and Achievements
184.108.40.206 Mergers and Acquisitions
220.127.116.11 Company Overview
18.104.22.168 Product Portfolio
22.214.171.124 Demographic Reach and Achievements
126.96.36.199 Mergers and Acquisitions
9 Recommendations and Discussion
10 Pricing Models and Strategies (Additional Insight)
10.2 Cost Model
10.2.1 Manufacturing Cost Analysis
10.2.2 Procurement Cost Analysis
10.2.3 Clinical Trial Cost Factors
10.3 Pricing Strategies
10.3.1 Competitor pricing Analysis
10.3.2 Key assessment of product attributes
10.3.3 Pricing Benchmark
11 Global Cardiac Mapping System Distribution Model (Additional Insight)
11.2 Potential Distributors
11.3 Key Parameters for Distribution Partner Assessment
Cardiac mapping systems are the mapping devices used to measure the heart’s electrical impulses and create an extensive three-dimensional image of the heart’s anatomy.
The market is expected to grow at a CAGR rate of 8.5% during the forecast period.
The two major types of cardiac mapping systems are contact mapping-based and non-contact mapping-based systems.
The cardiac mapping systems are used to diagnose and manage atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT) and other arrhythmias.
The major factors driving the growth of the cardiac mapping systems market are the rising prevalence of cardiovascular disorders and novel product launches and approvals.
The different end users in this market are hospitals, testing laboratories, research laboratories, and individuals.
The regions involved in this market are North America, Latin America, Asia Pacific, Europe and LATAM.
North America accounts for the maximum cardiac mapping systems market share.
The incorporation of magnetic technology, hybrid of impedance and magnetic-based technologies, artificial intelligence, etc., are some emerging technologies in cardiac mapping systems.
The key companies are Biosense Webster, Abbott Laboratories, Medtronics PLC, Boston Scientific Corporation, Acutus Medical, Microport Scientific Corporation, CoreMap Inc., APN Health LLC, BioSig Technologies Inc., Biotronik SE and Co KG, Koninklijke Philips NV, Angiodynamics, among others.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.